Impairment of T cells' antiviral and anti-inflammation immunities may be critical to death from COVID-19
Clarifying dominant factors determining the immune heterogeneity from non-survivors to survivors is crucial for developing therapeutics and vaccines against COVID-19. The main difficulty is quantitatively analysing the multi-level clinical data, including viral dynamics, immune response and tissue d...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Royal Society
2021-12-01
|
Series: | Royal Society Open Science |
Subjects: | |
Online Access: | https://royalsocietypublishing.org/doi/10.1098/rsos.211606 |